Benlysta For Lupus Likely To Be Approved This Thursday, A Potential Blockbuster

Links shared publicly online about this topic.

456
total visits

Benlysta For Lupus Likely To Be Approved This Thursday, A Potential Blockbuster

Benlysta (belimumab) is expected to gain US approval this week by the Food and Drug Administration (FDA), USA, for the treatment of lupus (systemic lupus erythematosus). This is the first drug app

View full resource at medicalnewstoday.com

Tags: Vaccination, Lupus, Systemic Lupus Erythematosus, Diet and Nutrition, Drug, FDA, Vaccine

Most Recently Shared on March 8, 2011 at 12:40 am By:

Health Feed

Benlysta For Lupus Likely To Be Approved This Thursday, A Potential Blockbuster http://ow.ly/1bEZXu

1 year ago...

Retweet

Favorite

Also Shared By:

Benlysta For Lupus Likely To Be Approved This Thursday, A Potential Blockbuster - QualityPoint Technologies

qualitypointtech.net — “Benlysta (belimumab) is expected to gain US approval this week by the Food and Drug Administration (FDA), USA, for the treatment of lupus (systemic lupus erythematosus). This is the first drug approval with benefits for lupus patients in half-a-century. Pharmaceutical experts believe Benlysta will become a huge blockbuster, with potentially $3 billion plus global annual sales within the next four years. They also add that approval is highly likely this coming Thursday. Human Genome Sciences, the” View full resource at qualitypointtech.net